Inomycin a new antibiotic of the cycloheximide group. II. Isolation and characterization of the antibiotic.
D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000633:toxicity; D000903:Antibiotics, Antineoplastic / Q000302:isolation & purification; D000935:Antifungal Agents / Q000302:isolation & purification; D001230:Aspergillus / Q000187:drug effects; D001412:Bacillus subtilis / Q000187:drug effects; D001431:Bacteriological Techniques; D002175:Candida / Q000187:drug effects; D002854:Chromatography, Paper; D003513:Cycloheximide / Q000032:analysis / Q000302:isolation & purification* / Q000633:toxicity; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D009161:Mycobacterium / Q000187:drug effects; D009584:Nitrogen / Q000032:analysis; D010407:Penicillium / Q000187:drug effects; D012440:Saccharomyces / Q000187:drug effects; D012509:Sarcoma / Q000517:prevention & control; D013057:Spectrum Analysis; D013297:Streptococcus pyogenes / Q000187:drug effects; D013302:Streptomyces / Q000032:analysis*
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; D003513:Cycloheximide; D009584:Nitrogen